Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

SOLATENE

BETA CAROTENE

Standard Dose
30MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview SOLATENE is listed in Drugs@FDA under application 017589 (NDA).

Marketing status: Discontinued Active ingredient BETA CAROTENE Form and strength CAPSULE;ORAL - 30MG Sponsor ROCHE Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview SOLATENE is listed in Drugs@FDA under application 017589 (NDA). Marketing status: Discontinued Active ingredient BETA CAROTENE Form and strength CAPSULE;ORAL - 30MG Sponsor ROCHE Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.